The therapeutic potential of psychedelic drugs: past, present and future

File Description SizeFormat 
Circumspectives_PDF.pdfAccepted version505.59 kBAdobe PDFView/Open
Title: The therapeutic potential of psychedelic drugs: past, present and future
Authors: Carhart-Harris, RL
Goodwin, GM
Item Type: Journal Article
Abstract: Plant-based psychedelics, such as psilocybin, have an ancient history of medicinal use. After the first English language report on LSD in 1950, psychedelics enjoyed a short-lived relationship with psychology and psychiatry. Used most notably as aids to psychotherapy for the treatment of mood disorders and alcohol dependence, drugs such as LSD showed initial therapeutic promise before prohibitive legislature in the mid-1960s effectively ended all major psychedelic research programs. Since the early 1990s, there has been a steady revival of human psychedelic research: last year saw reports on the first modern brain imaging study with LSD and three separate clinical trials of psilocybin for depressive symptoms. In this circumspective piece, RLC-H and GMG share their opinions on the promises and pitfalls of renewed psychedelic research, with a focus on the development of psilocybin as a treatment for depression.
Issue Date: 17-May-2017
Date of Acceptance: 20-Apr-2017
ISSN: 1740-634X
Publisher: Nature Publishing Group
Start Page: 2105
End Page: 2113
Journal / Book Title: Neuropsychopharmacology
Volume: 42
Copyright Statement: © 2017 American College of Neuropsychopharmacology. All rights reserved
Keywords: 11 Medical And Health Sciences
17 Psychology And Cognitive Sciences
Publication Status: Published
Appears in Collections:Department of Medicine
Faculty of Medicine

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons